Uwe Reichmann
Medical · Annapolis, MDNPI 1518277698
Payments from drug & device makers
Across 271 payments — averaging $22.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$1K
- Sanofi$751
- Regeneron Healthcare Solutions, Inc.$530
- Novartis$529
- Genentech USA, Inc.$332
- plus $2K from 20 others
What the payments were for
- Food & beverage$5,962100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 57 | $1,144 |
| GSK | 49 | $1,025 |
| Sanofi | 29 | $751 |
| Regeneron Healthcare Solutions, Inc. | 19 | $530 |
| Novartis | 25 | $529 |
| Genentech USA, Inc. | 13 | $332 |
| Kaleo, Inc. | 12 | $247 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $217 |
| Optinose US, Inc. | 13 | $197 |
| Amgen | 9 | $193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $147 |
| Pfizer | 7 | $123 |
| Aimmune Therapeutics, Inc. | 5 | $117 |
| Biocryst US Sales Co., LLC | 3 | $86 |
| Aytu Biopharma, Inc. | 2 | $47 |
| Blueprint Medicines Corporation | 1 | $38 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| Merck | 2 | $37 |
| Pharming Healthcare, Inc. | 1 | $26 |
| CSL Behring | 1 | $24 |
| Ionis Pharmaceuticals, Inc. | 1 | $23 |
| Incyte Corporation | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Grifols USA, LLC | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $13 |
How this compares
$5,962 in reported general payments places this provider in the 85th percentile of 543 medical providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 17 | $99,583 |
| XolairOmalizumab | 17 | $44,460 |
| Levocetirizine Dihydrochloride | 101 | $2,513 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,737 |
| Fluticasone Propionate | 45 | $1,553 |
| Azelastine Hcl | 24 | $1,433 |
| Famotidine | 34 | $542 |
| Ipratropium Bromide | 13 | $451 |
| Hydroxyzine Hcl | 37 | $445 |
| Montelukast Sodium | 18 | $408 |
| Pantoprazole Sodium | 19 | $317 |
| Cefdinir | 13 | $315 |
| Prednisone | 21 | $52 |
Paid to pharmacies, not to this prescriber.
Other medical in Annapolis
- Karen ScottAnnapolis$49K
- Mary HolthausAnnapolis$11K
- Molly WarnockAnnapolis$8K
- Victoria TrottStevensville$94K
- Sarah SagorskyBaltimore$68K
- Emily GrisnikLeonardtown$62K
- Jennifer HamiltonBel Air$52K
- Kristina TrunnellFrederick$51K
- Nicholas WunderAberdeen$40K
- Sarah JamiesonFrederick$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.